BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25676692)

  • 1. Establishment of a novel system for the culture and expansion of hepatic stem-like cancer cells.
    Li J; Yu Y; Wang J; Yan Z; Liu H; Wang Y; Ding M; Cui L; Wu M; Jiang X; Qian Q
    Cancer Lett; 2015 May; 360(2):177-86. PubMed ID: 25676692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.
    Muramatsu S; Tanaka S; Mogushi K; Adikrisna R; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Nakayama K; Tanaka H; Yamaoka S; Arii S
    Hepatology; 2013 Jul; 58(1):218-28. PubMed ID: 23447025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
    Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
    J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of cancer stem cell-like cells by culture in alginate gel beads.
    Xu XX; Liu C; Liu Y; Yang L; Li N; Guo X; Sun GW; Ma XJ
    J Biotechnol; 2014 May; 177():1-12. PubMed ID: 24607645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells.
    Zhu P; Wang Y; He L; Huang G; Du Y; Zhang G; Yan X; Xia P; Ye B; Wang S; Hao L; Wu J; Fan Z
    J Clin Invest; 2015 Oct; 125(10):3795-808. PubMed ID: 26426078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of hepatic cancer stem cells.
    Tong CM; Ma S; Guan XY
    J Gastroenterol Hepatol; 2011 Aug; 26(8):1229-37. PubMed ID: 21557770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
    Chiba T; Kamiya A; Yokosuka O; Iwama A
    Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
    Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
    Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tumor-initiating cells in a canine hepatocellular carcinoma cell line.
    Michishita M; Ezaki S; Ogihara K; Naya Y; Azakami D; Nakagawa T; Sasaki N; Arai T; Shida T; Takahashi K
    Res Vet Sci; 2014 Apr; 96(2):315-22. PubMed ID: 24534130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics.
    Noto Z; Yoshida T; Okabe M; Koike C; Fathy M; Tsuno H; Tomihara K; Arai N; Noguchi M; Nikaido T
    Oral Oncol; 2013 Aug; 49(8):787-95. PubMed ID: 23768762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.
    Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S
    Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation inhibition and differentiation induction of hepatic cancer stem cells by knockdown of BC047440: a potential therapeutic target of stem cell treatment for hepatocellular carcinoma.
    You N; Zheng L; Liu W; Zhong X; Wang W; Li J
    Oncol Rep; 2014 Apr; 31(4):1911-20. PubMed ID: 24573111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient enrichment of hepatic cancer stem-like cells from a primary rat HCC model via a density gradient centrifugation-centered method.
    Liu WH; Wang X; You N; Tao KS; Wang T; Tang LJ; Dou KF
    PLoS One; 2012; 7(4):e35720. PubMed ID: 22558209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective enrichment of hepatocellular cancer stem cells by chemotherapy.
    Tan S; Chen JS; Sun LJ; Yao HR
    J Int Med Res; 2009; 37(4):1046-56. PubMed ID: 19761687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
    Li Y; Tang Z; Ye S; Liu Y; Chen J; Xue Q; Huang X; Chen J; Bao W; Yang J; Gao D
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):601-5. PubMed ID: 12133480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new method for purification and identification of hepatocellular carcinoma stem cell of SMMC-7721].
    Wang Y; Liu YH; Jiang JS; Cui HB
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3434-7. PubMed ID: 23327707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a stem-like population in hepatocellular carcinoma MHCC97 cells.
    Zhang N; Li R; Tao KS; Cao DY; Ti ZY; Ding R; Cai L; Zhang FQ; Dou KF
    Oncol Rep; 2010 Mar; 23(3):827-31. PubMed ID: 20127026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of local and circulating cancer stem cells in human liver cancer.
    Yang ZF; Ngai P; Ho DW; Yu WC; Ng MN; Lau CK; Li ML; Tam KH; Lam CT; Poon RT; Fan ST
    Hepatology; 2008 Mar; 47(3):919-28. PubMed ID: 18275073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic target for cancer stem cells in hepatocellular carcinoma.
    Nagano H; Ishii H; Marubashi S; Haraguchi N; Eguchi H; Doki Y; Mori M
    J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):600-5. PubMed ID: 22892595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.